What are mostUndervalued drug manufacturers - general stocks?
They are Drug Manufacturers - General names trading below modeled intrinsic value—shown here as upside % versus price. Models vary; use this as a screen, not advice.
Search companies or stocks...
Top MostUndervalued Drug Manufacturers - General industry Stocks 2026
Grifols, S.A. (GRFS) is the most undervalued stock in the Drug Manufacturers - General industry with an estimated 305.0% upside, followed by Sanofi (SNY) at 120.0%, Bristol-Myers Squibb Company (BMY) at 69.3%, and Organon & (OGN) at 69.2%.
Updated todayBased on intrinsic value modelsIndustry: Drug Manufacturers - General
Page snapshot: 28 July 2026, 12:11 am
View full analysis in the screener → · All most undervalued stocks →
Before you trade on valuation alone
Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.
Drug Manufacturers - General Industry Valuation Insights (Updated Today)
- The Drug Manufacturers - General industry currently shows an average upside of 108.0% on this snapshot.
- Top name Grifols, S.A. (GRFS) trades at roughly a 305.0% discount to modeled intrinsic value—rankings move with prices and inputs.
- This industry's average upside is below our broad mostUndervalued benchmark (~605.0%).
MostUndervalued Drug Manufacturers - General Stocks by Market Cap
Large cap (top 5)
- 1.Sanofi · SNY120.0%$105.16B
- 2.Bristol-Myers Squibb Company · BMY69.3%$126.79B
- 3.Novo Nordisk A/S · NVO44.2%$216.72B
- 4.Biogen Inc. · BIIB40.4%$29.85B
Mid cap (top 5)
- 1.Grifols, S.A. · GRFS305.0%$6.41B
- 2.Organon & Co. · OGN69.2%$3.55B
Small cap (top 5)
No qualifying names in this bucket on this snapshot.
What Are the Most Undervalued Drug Manufacturers - General Stocks?
Most undervalued drug manufacturers - general stocks are names where price sits furthest below modeled fair (intrinsic) value—often expressed as the largest headline upside versus price.
This is not a buy list. Validate each symbol on its company page before you act.
How We Identify the Most Undervalued Drug Manufacturers - General Stocks
We pull an industry-filtered most-undervalued snapshot (price, intrinsic value, upside, cap, sector, country) and rank by headline upside. You can sort and search in the table above.
Rankings can shift intraday as prices and model inputs move. Use the stock screener for custom filters beyond this industry leaderboard.
FAQs
Answers about the most undervalued drug manufacturers - general names, intrinsic value, and how often this list refreshes.
How do you find mostUndervalued drug manufacturers - general stocks?
We load mostUndervalued names for this industry from our API, then rank and filter in the table. Sort columns and open company pages to dig deeper.
Why are drug manufacturers - general stocks mostUndervalued?
Often sentiment, earnings, cycles, rates, or stock-specific news—not always a “misprice.” Intrinsic value is model-dependent.
Are mostUndervalued drug manufacturers - general stocks a good investment?
Not by label alone. Discounts can reflect risk or data lag. Check fundamentals and your goals; seek professional advice if needed.
How often is this list updated?
The page rebuilds on a schedule (ISR). Live quotes can move faster—use company pages for the latest.